리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 08월
페이지 정보:영문 503 Pages
라이선스 & 가격 (부가세 별도)
한글목차
임상시험 공급 및 물류 세계 시장은 2030년까지 52억 달러에 이를 것으로 예상
2023년에 36억 달러로 추정되는 임상시험 공급 및 물류 세계 시장은 2023-2030년간 CAGR 5.5%로 성장하며 2030년에는 52억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 물류·유통 서비스는 CAGR 6.0%로 성장을 지속하고, 분석 기간 종료 시에는 14억 달러에 달할 것으로 예측됩니다. 비교기 소싱 서비스 분야의 성장률은 분석 기간 동안 CAGR 5.0%로 추정됩니다.
미국 시장은 추정 9억 7,800만 달러, 중국은 CAGR 9.0%로 성장 예측
2023년 미국 임상시험 공급 및 물류시장은 9억 7,800만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 11억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023-2030년의 CAGR은 9.0%입니다. 기타 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.2%와 5.6%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.4%로 성장할 것으로 예측됩니다.
세계의 임상시험 공급 및 물류 시장 - 주요 동향과 촉진요인 요약
임상시험 공급 및 물류는 임상 연구를 성공시키는 데 중요한 역할을합니다. 이 전문 분야에서는 임상시험제의 조달, 관리, 유통에 더하여 임상시험실시시설에 필요한 장비와 보조비품이 포함됩니다. 이러한 컴포넌트가 제 시간에 적절한 조건에서 규제 기준을 준수하고 전달되도록 보장하는 것은 임상시험 프로세스의 무결성을 유지하는 데 가장 중요합니다. 이 복잡한 물류 네트워크에는 제약 회사, 의약품 개발 업무 수탁 기관(CRO) 및 다양한 공급망 파트너 간의 조정이 포함되어 있으며, 각각이 여러 지역에 걸쳐 임상시험의 원활한 운영에 기여합니다.
임상시험 공급과 물류의 최근 발전은 효율성과 신뢰성을 크게 향상 시켰습니다. 실시간 추적 및 모니터링 시스템과 같은 기술 통합을 통해 공급망의 가시성과 관리가 개선되었으며 이해 관계자는 배송을 정확하게 추적하고 문제가 발생하면 신속하게 대응할 수 있습니다. 패키징과 콜드체인 물류의 혁신은 특히 생물학적 제제 및 기타 온도에 민감하고 엄격한 보관 조건이 필요한 제품에 매우 중요합니다. 또한 블록체인 기술의 활용은 공급망 전반에 걸쳐 데이터 무결성과 추적성을 확보하고 임상시험 업무의 투명성과 안전성을 높이는 혁신 도구로 부상하고 있습니다.
임상시험 공급과 물류 시장의 성장은 여러 요인에 의해 초래됩니다. 첫째, 임상시험의 복잡화와 세계화에 따라 다기관시험과 다양한 규제환경을 관리하는 견고한 물류 솔루션이 필요합니다. 둘째, 생물학적 제제와 맞춤형 의료가 증가함에 따라 특수한 취급과 보관이 필요하며, 첨단 물류 기능에 대한 수요가 증가하고 있습니다. 또한 실시간 추적, AI 주도 예측 분석, 블록체인 등의 기술적 진보가 공급체인 관리에 혁명을 일으켜 보다 효율적이고 신뢰성이 높아지고 있습니다. COVID-19의 대유행은 민첩하고 탄력적인 공급망의 중요성을 돋보이게 하고 공급망 인프라에 대한 투자 확대를 촉진하고 있습니다. 게다가 제약기업이 임상시험 물류서비스를 CRO로 아웃소싱하는 경향이 커지고 시장 기회가 확대되고 있습니다. 마지막으로, 의약품 공급에 대한 엄격한 규제 요건은 컴플라이언스를 보장하고 위험을 줄이는 종합적인 물류 솔루션의 채택을 촉진하고 있습니다.
조사 대상 기업 예(전 56건)
Almac Group
Bilcare Ltd.
Biocair International Ltd.
Catalent, Inc.
Eurofins Scientific SE
Experic
ICON plc
Intertek Group PLC
IQVIA Inc.
Lonza Group Ltd.
Movianto
Oximio
Parexel International(MA) Corporation
PCI Pharma Services
Piramal Pharma Solutions;
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
JHS
영문 목차
영문목차
Global Clinical Trial Supply and Logistics Market to Reach US$5.2 Billion by 2030
The global market for Clinical Trial Supply and Logistics estimated at US$3.6 Billion in the year 2023, is expected to reach US$5.2 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Logistics & Distribution Services, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Comparator Sourcing Services segment is estimated at 5.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$978.0 Million While China is Forecast to Grow at 9.0% CAGR
The Clinical Trial Supply and Logistics market in the U.S. is estimated at US$978.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.
Global Clinical Trial Supply and Logistics Market - Key Trends and Drivers Summarized
Clinical trial supply and logistics play a critical role in the successful execution of clinical research. This specialized field encompasses the sourcing, management, and distribution of investigational products, as well as the necessary equipment and ancillary supplies to clinical trial sites. Ensuring that these components are delivered on time, in the right condition, and in compliance with regulatory standards is paramount to maintaining the integrity of the clinical trial process. This intricate logistics network involves coordination between pharmaceutical companies, contract research organizations (CROs), and various supply chain partners, each contributing to the seamless operation of clinical trials across multiple regions.
Recent advancements in clinical trial supply and logistics are significantly enhancing efficiency and reliability. Technology integration, such as real-time tracking and monitoring systems, has improved the visibility and management of supply chains, enabling stakeholders to track shipments accurately and respond swiftly to any issues that arise. Innovations in packaging and cold chain logistics are also crucial, particularly for biologics and other temperature-sensitive products that require stringent storage conditions. Additionally, the use of blockchain technology is emerging as a transformative tool for ensuring data integrity and traceability throughout the supply chain, thus enhancing transparency and security in clinical trial operations.
The growth in the clinical trial supply and logistics market is driven by several factors. Firstly, the increasing complexity and globalization of clinical trials necessitate robust logistics solutions to manage multi-site studies and diverse regulatory environments. Secondly, the rise in biologics and personalized medicine, which often require specialized handling and storage, is propelling demand for advanced logistics capabilities. Furthermore, technological advancements such as real-time tracking, AI-driven predictive analytics, and blockchain are revolutionizing the supply chain management, making it more efficient and reliable. The COVID-19 pandemic has also underscored the importance of agile and resilient supply chains, prompting greater investment in supply chain infrastructure. Additionally, the growing outsourcing trend among pharmaceutical companies to CROs for clinical trial logistics services is expanding market opportunities. Lastly, stringent regulatory requirements for clinical trial supplies are driving the adoption of comprehensive logistics solutions to ensure compliance and mitigate risks.
Select Competitors (Total 56 Featured) -
Almac Group
Bilcare Ltd.
Biocair International Ltd.
Catalent, Inc.
Eurofins Scientific SE
Experic
ICON plc
Intertek Group PLC
IQVIA Inc.
Lonza Group Ltd.
Movianto
Oximio
Parexel International (MA) Corporation
PCI Pharma Services
Piramal Pharma Solutions;
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Clinical Trial Supply and Logistics - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Complexity of Clinical Trials Drives Demand for Specialized Logistics
Technological Advancements in Supply Chain Management Strengthen Efficiency
Expansion of Biopharmaceuticals Spurs Need for Reliable Supply Solutions
Rising Number of Clinical Trials Generates Demand for Logistics Services
Adoption of Cold Chain Technologies Enhances Product Integrity
Focus on Patient-Centric Approaches Drives Innovations in Supply Solutions
Increasing R&D Investments in Pharma Sustain Market Growth
Outsourcing Trends in Pharma and Biotech Propel Market
Collaboration Between Pharma Companies and Logistics Providers Accelerates Growth
Emphasis on Quality Assurance and Compliance Drives Adoption
Adoption of Green Logistics and Sustainable Practices Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Clinical Trial Supply and Logistics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Clinical Trial Supply and Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Clinical Trial Supply and Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Logistics & Distribution Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Logistics & Distribution Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Logistics & Distribution Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Comparator Sourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Comparator Sourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Comparator Sourcing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Manufacturing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Manufacturing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Manufacturing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Packaging, Labeling, & Blinding Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Packaging, Labeling, & Blinding Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Packaging, Labeling, & Blinding Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Storage & Retention Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Storage & Retention Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Storage & Retention Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Phase IV Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Phase IV Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Phase IV Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Phase I Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Phase I Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Phase I Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Phase II Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Phase II Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Phase II Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Phase III Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Phase III Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Phase III Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Cardiovascular Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 39: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Respiratory Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 42: World Historic Review for Respiratory Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: World 16-Year Perspective for Respiratory Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 44: World Recent Past, Current & Future Analysis for CNS & Mental Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 45: World Historic Review for CNS & Mental Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: World 16-Year Perspective for CNS & Mental Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 47: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 48: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 50: World Recent Past, Current & Future Analysis for Pharmaceutical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 51: World Historic Review for Pharmaceutical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: World 16-Year Perspective for Pharmaceutical End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 53: World Recent Past, Current & Future Analysis for Medical Devices End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 54: World Historic Review for Medical Devices End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: World 16-Year Perspective for Medical Devices End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 56: World Recent Past, Current & Future Analysis for Biologicals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 57: World Historic Review for Biologicals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: World 16-Year Perspective for Biologicals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 59: USA Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: USA Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: USA 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 62: USA Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: USA Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: USA 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 65: USA Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: USA Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: USA 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 68: USA Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: USA Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: USA 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
CANADA
TABLE 71: Canada Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Canada Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Canada 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 74: Canada Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Canada Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Canada 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 77: Canada Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Canada Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Canada 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 80: Canada Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Canada Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Canada 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
JAPAN
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 83: Japan Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Japan Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Japan 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 86: Japan Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Japan Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Japan 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 89: Japan Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Japan Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Japan 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 92: Japan Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Japan Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Japan 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
CHINA
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 95: China Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: China Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: China 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 98: China Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: China Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: China 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 101: China Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: China Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: China 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 104: China Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: China Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: China 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
EUROPE
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 107: Europe Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 108: Europe Historic Review for Clinical Trial Supply and Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Europe 16-Year Perspective for Clinical Trial Supply and Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 110: Europe Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Europe Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Europe 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 113: Europe Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Europe Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Europe 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 116: Europe Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: Europe Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Europe 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 119: Europe Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Europe Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Europe 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
FRANCE
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 122: France Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: France Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: France 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 125: France Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: France Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: France 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 128: France Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: France Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: France 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 131: France Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: France Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: France 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
GERMANY
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 134: Germany Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Germany Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Germany 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 137: Germany Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Germany Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Germany 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 140: Germany Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Germany Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Germany 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 143: Germany Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Germany Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Germany 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
ITALY
TABLE 146: Italy Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Italy Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Italy 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 149: Italy Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Italy Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Italy 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 152: Italy Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Italy Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Italy 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 155: Italy Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Italy Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Italy 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
UNITED KINGDOM
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 158: UK Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: UK Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: UK 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 161: UK Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: UK Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: UK 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 164: UK Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: UK Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: UK 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 167: UK Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: UK Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: UK 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
SPAIN
TABLE 170: Spain Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Spain Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Spain 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 173: Spain Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Spain Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Spain 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 176: Spain Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Spain Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Spain 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 179: Spain Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Spain Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Spain 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
RUSSIA
TABLE 182: Russia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Russia Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Russia 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 185: Russia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Russia Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Russia 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 188: Russia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Russia Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Russia 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 191: Russia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Russia Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Russia 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Europe Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Europe 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Europe Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Europe 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Europe Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Europe 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Rest of Europe Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Rest of Europe 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 207: Asia-Pacific Historic Review for Clinical Trial Supply and Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Asia-Pacific 16-Year Perspective for Clinical Trial Supply and Logistics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Asia-Pacific Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Asia-Pacific 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Asia-Pacific Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Asia-Pacific 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Asia-Pacific Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Asia-Pacific 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Asia-Pacific Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Asia-Pacific 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
AUSTRALIA
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 221: Australia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Australia Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Australia 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 224: Australia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Australia Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Australia 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 227: Australia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 228: Australia Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 229: Australia 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 230: Australia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 231: Australia Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 232: Australia 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
INDIA
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 233: India Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 234: India Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 235: India 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 236: India Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 237: India Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 238: India 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 239: India Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 240: India Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 241: India 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 242: India Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 243: India Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 244: India 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 245: South Korea Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 246: South Korea Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 247: South Korea 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 248: South Korea Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 249: South Korea Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 250: South Korea 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 251: South Korea Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 252: South Korea Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 253: South Korea 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 254: South Korea Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 255: South Korea Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 256: South Korea 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 258: Rest of Asia-Pacific Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 261: Rest of Asia-Pacific Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 264: Rest of Asia-Pacific Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 267: Rest of Asia-Pacific Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
LATIN AMERICA
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 269: Latin America Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 270: Latin America Historic Review for Clinical Trial Supply and Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 271: Latin America 16-Year Perspective for Clinical Trial Supply and Logistics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 272: Latin America Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 273: Latin America Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 274: Latin America 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 275: Latin America Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 276: Latin America Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 277: Latin America 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 278: Latin America Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 279: Latin America Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 280: Latin America 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 281: Latin America Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 282: Latin America Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 283: Latin America 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 284: Argentina Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 285: Argentina Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 286: Argentina 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 287: Argentina Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 288: Argentina Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 289: Argentina 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 290: Argentina Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 291: Argentina Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 292: Argentina 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 293: Argentina Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 294: Argentina Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 295: Argentina 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
BRAZIL
TABLE 296: Brazil Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 297: Brazil Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 298: Brazil 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 299: Brazil Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 300: Brazil Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 301: Brazil 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 302: Brazil Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 303: Brazil Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 304: Brazil 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 305: Brazil Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 306: Brazil Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 307: Brazil 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
MEXICO
TABLE 308: Mexico Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 309: Mexico Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 310: Mexico 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 311: Mexico Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 312: Mexico Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 313: Mexico 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 314: Mexico Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 315: Mexico Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 316: Mexico 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 317: Mexico Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 318: Mexico Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 319: Mexico 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 321: Rest of Latin America Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 322: Rest of Latin America 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 324: Rest of Latin America Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 325: Rest of Latin America 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 327: Rest of Latin America Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 328: Rest of Latin America 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 330: Rest of Latin America Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 331: Rest of Latin America 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
MIDDLE EAST
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 332: Middle East Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 333: Middle East Historic Review for Clinical Trial Supply and Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 334: Middle East 16-Year Perspective for Clinical Trial Supply and Logistics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 335: Middle East Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 336: Middle East Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 337: Middle East 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 338: Middle East Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 339: Middle East Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 340: Middle East 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 341: Middle East Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 342: Middle East Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 343: Middle East 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 344: Middle East Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 345: Middle East Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 346: Middle East 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
IRAN
TABLE 347: Iran Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 348: Iran Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 349: Iran 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 350: Iran Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 351: Iran Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 352: Iran 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 353: Iran Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 354: Iran Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 355: Iran 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 356: Iran Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 357: Iran Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 358: Iran 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
ISRAEL
TABLE 359: Israel Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 360: Israel Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 361: Israel 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 362: Israel Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 363: Israel Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 364: Israel 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 365: Israel Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 366: Israel Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 367: Israel 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 368: Israel Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 369: Israel Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 370: Israel 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 372: Saudi Arabia Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 373: Saudi Arabia 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 375: Saudi Arabia Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 376: Saudi Arabia 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 378: Saudi Arabia Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 379: Saudi Arabia 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 381: Saudi Arabia Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 382: Saudi Arabia 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 383: UAE Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 384: UAE Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 385: UAE 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 386: UAE Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 387: UAE Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 388: UAE 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 389: UAE Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 390: UAE Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 391: UAE 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 392: UAE Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 393: UAE Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 394: UAE 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 396: Rest of Middle East Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 397: Rest of Middle East 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR<
li>TABLE 399: Rest of Middle East Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 400: Rest of Middle East 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 402: Rest of Middle East Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 403: Rest of Middle East 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 405: Rest of Middle East Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 406: Rest of Middle East 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
AFRICA
Clinical Trial Supply and Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 407: Africa Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 408: Africa Historic Review for Clinical Trial Supply and Logistics by Service - Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 409: Africa 16-Year Perspective for Clinical Trial Supply and Logistics by Service - Percentage Breakdown of Value Sales for Logistics & Distribution Services, Comparator Sourcing Services, Manufacturing Services, Packaging, Labeling, & Blinding Services, Storage & Retention Services and Other Services for the Years 2014, 2024 & 2030
TABLE 410: Africa Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 411: Africa Historic Review for Clinical Trial Supply and Logistics by Trial Phase - Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 412: Africa 16-Year Perspective for Clinical Trial Supply and Logistics by Trial Phase - Percentage Breakdown of Value Sales for Phase IV Trials, Phase I Trials, Phase II Trials and Phase III Trials for the Years 2014, 2024 & 2030
TABLE 413: Africa Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 414: Africa Historic Review for Clinical Trial Supply and Logistics by Application - Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 415: Africa 16-Year Perspective for Clinical Trial Supply and Logistics by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application and Other Applications for the Years 2014, 2024 & 2030
TABLE 416: Africa Recent Past, Current & Future Analysis for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 417: Africa Historic Review for Clinical Trial Supply and Logistics by End-Use - Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 418: Africa 16-Year Perspective for Clinical Trial Supply and Logistics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Medical Devices End-Use and Biologicals End-Use for the Years 2014, 2024 & 2030
